BioMark Diagnostics Inc.
BMKDF
$0.43
$0.038.48%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -143.40K | -272.80K | -349.50K | -300.70K | -294.00K |
| Total Depreciation and Amortization | 39.10K | 101.20K | 62.80K | 72.60K | 158.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 22.00K | 25.20K | 14.60K | 11.00K | 29.00K |
| Change in Net Operating Assets | -3.70K | 1.80K | -77.80K | 10.60K | -207.90K |
| Cash from Operations | -86.10K | -144.60K | -349.80K | -206.50K | -314.90K |
| Capital Expenditure | 448.60K | -442.90K | -6.30K | -1.40K | -700.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 292.40K | 18.40K | 768.40K | -1.36M | -- |
| Cash from Investing | 741.10K | -424.50K | 762.10K | -1.36M | -700.00 |
| Total Debt Issued | -557.20K | 735.80K | 89.30K | 89.30K | 89.30K |
| Total Debt Repaid | -268.20K | -152.90K | -147.50K | -189.00K | -174.00K |
| Issuance of Common Stock | 22.50K | -- | -- | -- | 2.93M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 23.40K | -23.40K | -- | -- | -- |
| Cash from Financing | -560.50K | 401.40K | -42.20K | -72.10K | 1.98M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 94.50K | -167.70K | 370.00K | -1.64M | 1.67M |